Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

[1]  S. Caruthers,et al.  Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  D. Broome,et al.  Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. , 2008, European journal of radiology.

[3]  C. Barbatis,et al.  Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. , 2007, Atherosclerosis.

[4]  N. Caplice,et al.  Plaque neovascularization and antiangiogenic therapy for atherosclerosis. , 2007, Journal of the American College of Cardiology.

[5]  R. Virmani,et al.  Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? , 2007, Journal of the American College of Cardiology.

[6]  D. McDonald,et al.  Mechanisms of adverse effects of anti-VEGF therapy for cancer , 2007, British Journal of Cancer.

[7]  Garry E. Kiefer,et al.  Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .

[8]  Samuel A. Wickline,et al.  Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .

[9]  R. Virmani,et al.  Statin Treatment Is Not Associated With Consistent Alterations in Inflammatory Status of Carotid Atherosclerotic Plaques: A Retrospective Study in 378 Patients Undergoing Carotid Endarterectomy , 2006, Stroke.

[10]  Marc Sirol,et al.  Neovascularization in Human Atherosclerosis , 2006, Circulation.

[11]  Aloke V. Finn,et al.  Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[12]  M. Simons,et al.  Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal , 2005, Circulation.

[13]  Chun Yuan,et al.  Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.

[14]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[15]  A. Sinusas,et al.  Detection of Injury-Induced Vascular Remodeling by Targeting Activated &agr;vβ3 Integrin In Vivo , 2004 .

[16]  D. Harrison,et al.  Vascular Oxidant Stress Enhances Progression and Angiogenesis of Experimental Atheroma , 2004, Circulation.

[17]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[18]  P. Libby,et al.  Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Claude Lenfant,et al.  ACC/AHA/NHLBI clinical advisory on the use and safety of statins. , 2002, Journal of the American College of Cardiology.

[20]  P. Weissberg,et al.  Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis , 2000, The Journal of pathology.

[21]  W. DeGrado,et al.  The Activation State of αvβ3Regulates Platelet and Lymphocyte Adhesion to Intact and Thrombin-cleaved Osteopontin* , 2000, The Journal of Biological Chemistry.

[22]  J. Henkin,et al.  Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases , 2000, Journal of cellular biochemistry.

[23]  J. Marshall,et al.  A Phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[25]  J. M. Isner.  Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.

[26]  O. Wiklund,et al.  Evidence of hypoxic areas within the arterial wall in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[27]  R. Solà,et al.  Simvastatin decreases aldehyde production derived from lipoprotein oxidation. , 1999, The American journal of cardiology.

[28]  A. Becker,et al.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.

[29]  Eric C. Griffith,et al.  Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Widom,et al.  Structure of human methionine aminopeptidase-2 complexed with fumagillin. , 1998, Science.

[31]  C. Verschraegen,et al.  Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. , 1998, The New England journal of medicine.

[32]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[33]  D. Granger,et al.  Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[34]  K. Kent,et al.  The role of integrins in saphenous vein vascular smooth muscle cell migration. , 1997, Journal of vascular surgery.

[35]  Chandra L. Theesfeld,et al.  Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R A Bradshaw,et al.  Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  G. Burns,et al.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Cheresh.  Integrins in thrombosis, wound healing and cancer. , 1991, Biochemical Society transactions.

[39]  Orlando P Simonetti,et al.  In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques. , 2008, JACC. Cardiovascular imaging.